[Featured Stock] Bridge Biotherapeutics Shows Early Morning Strength
Bridge Biotherapeutics is showing strong early gains.
As of 9:06 AM on the 16th, Bridge Biotherapeutics is trading on the KOSDAQ market at 2,515 KRW, up 300 KRW (13.54%) from the previous trading day.
Hot Picks Today
The Quoted 800,000 Won, the Bill Was 5 Million....
- Tragedy in Luxury Apartment: Woman in Her 20s Found Dead, Suspect Identified
- They Say They'd Rather Go to Japan Than Travel Domestically... But a 'Surprising...
- "You Can Only Have This in Korea": Which National Museum Cafe Menu Is Captivatin...
- "Never Hike Alone as a Woman" "Even Two Are at Risk"... Growing Fear of Crime on...
Bridge Bio is in the process of raising funds in the 20 billion KRW range through a rights offering with a dilution ratio of approximately 49%. Through this capital increase, the company plans to proactively secure costs to accelerate the development of new drug candidates and resolve financial uncertainties.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
